Completed OBSERVATIONAL NCT05655689

The Antibiogram and Outcomes of Antimicrobial Regimens in Microbial Keratitis: A Prospective Cohort Study

Evaluation of Antibiogram Results and Clinical Response to Prescribed Antimicrobials in Microbial Keratitis Patients

Sponsor: Alexandria University

Conditions Bacterial Keratitis Fungal Keratitis Microbial Keratitis Mixed Bacterial and Fungal Keratitis

Interventions Ceftazidime 5% + vancomycin 5% Gentamicin 1.4% + vancomycin 5% Moxifloxacin Ophthalmic 0.5% Ophthalmic Solution Natamycin 5% + voriconazole 1% Natamycin 5% Oph Susp Natamycin 5%+ ceftazidime 5% + vancomycin 5% Voriconazole 1% Voriconazole 1% + ceftazidime 5% + vancomycin 5%

Updated 5 times since 2023 Last updated: Jan 24, 2024 Started: Dec 31, 2021 Primary completion: Jan 1, 2023 Completion: Jan 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05655689, this observational or N/A phase trial focuses on Bacterial Keratitis and Fungal Keratitis and remains completed. Sponsored by Alexandria University, it has been updated 5 times since 2021, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Feb 2024 — Jul 2024 [monthly]

Completed
Mar 2023 — Feb 2024 [monthly]

Completed

Status: Recruiting → Completed
Jan 2023 — Mar 2023 [monthly]

Recruiting

First recorded

Dec 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alexandria University

Data source: Alexandria University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Alexandria, Egypt